NLTX

Q: What is the price of Neoleukin Therapeutics (NLTX) today?

The price of Neoleukin Therapeutics (NLTX) today is $ 0.00, with return of 0% compared to the last year. The price of Neoleukin Therapeutics (NLTX) started the year trading around $ 0.00 and today it is at $ 0.00. Follow the real-time price chart, the historical price of Neoleukin Therapeutics (NLTX) and international markets.

Q: When does Neoleukin Therapeutics (NLTX) pay dividends?

Neoleukin Therapeutics (NLTX) did not distribute dividends in the last year.

Q: Is Neoleukin Therapeutics (NLTX) worth it?

Currently, Neoleukin Therapeutics (NLTX) is priced at $ 0.00, with a P/E of -0.59%, representing a deviation of -4,691% from its historical average P/E. In the last year, the stock showed a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 0.00%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Neoleukin Therapeutics (NLTX) stock?

Investing in stocks of Neoleukin Therapeutics (NLTX) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Neoleukin Therapeutics (NLTX) yield today?

The yield of Neoleukin Therapeutics (NLTX) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Neoleukin Therapeutics (NLTX) today, the total investment would be $ 0.00, based on the current price of $ 0.00.If past performance were to repeat, the return on your investment would be:In 1 year: $ 0.00In 5 years: $ 0.00In 10 years: $ 0.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Neoleukin Therapeutics Inc.

Price

$ -

return (12m)

0.00%

p/e

-0.59

p/bv

0.51

DIVIDEND YIELD

0.00%

price NLTX

NLTX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of NLTX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals NLTX

review the fundamentals of Neoleukin Therapeutics shares

P/E

-0.59

Sector: -3.74 Industry: -3.74

P/SALES RATIO (PSR)

Sector: -3.71 Industry: -3.71

P/BV

0.51

Sector: 2.05 Industry: 2.05

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-72.89%

Sector: -63.91% Industry: -63.91%

ROE

-86.79%

Sector: -67.36% Industry: -67.36%

ROIC

Sector: -1,129.15% Industry: -1,129.15%

NET MARGIN

0.00%

Sector: -41.63% Industry: -41.63%

GROSS MARGIN

0.00%

Sector: 39.39% Industry: 39.39%

OPERATING MARGIN

0.00%

Sector: -41.51% Industry: -41.51%

P/EBITDA

-0.73

Sector: -3.78 Industry: -3.78

P/EBIT

-0.69

Sector: -3.91 Industry: -3.91

P/ASSET

0.43

Sector: 1.49 Industry: 1.49

BVPS

6.78

Sector: 1.73 Industry: 1.73

EPS

-5.88

Sector: -2.05 Industry: -2.05

EQUITY RATIO

0.84

Sector: 0.41 Industry: 0.41

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

14.43%

Sector: - Industry: -

Fundamentals NLTX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	20.28	0.00	0.00%	2.43%	$ 509.48 B	27.26%
PFE	14.95	1.58	10.56%	6.65%	$ 146.96 B	15.65%
ABBV	168.68	-154.98	-91.88%	2.88%	$ 402.80 B	4.00%
NVO	13.80	7.96	57.70%	3.53%	$ 212.69 B	32.78%
MRK	13.09	0.00	0.00%	3.25%	$ 249.10 B	29.63%
AZN	29.65	6.06	20.45%	1.74%	$ 278.65 B	16.17%
BMY	17.58	5.71	32.47%	4.76%	$ 106.18 B	12.57%
GILD	18.45	6.98	37.80%	2.61%	$ 149.66 B	27.88%
ZTS	19.83	9.74	49.11%	1.69%	$ 52.56 B	28.21%
HALO	12.22	14.44	118.17%	0.00%	$ 7.28 B	47.91%
REGN	16.32	2.41	14.79%	0.49%	$ 74.71 B	32.13%
AMGN	24.40	17.77	72.82%	3.00%	$ 170.94 B	19.47%
VRTX	31.73	6.73	21.22%	0.00%	$ 116.60 B	31.35%
MCK	24.84	-173.31	-697.75%	0.37%	$ 100.18 B	1.04%
CAH	29.67	-17.33	-58.40%	1.02%	$ 47.32 B	0.68%
ADMA	22.57	10.96	48.57%	0.00%	$ 4.73 B	42.87%
BIIB	15.91	1.41	8.83%	0.00%	$ 25.59 B	15.98%
HRMY	12.65	2.81	22.24%	0.00%	$ 2.35 B	22.48%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

NLTX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY Neoleukin Therapeutics

Neoleukin Therapeutics Inc.

Average user rating I10

4.0 (0 people)

United States

18 years

Founded: 2007

2014

Time since IPO - 11 years

70

Employees

The Company Neoleukin Therapeutics Inc. (United States), is listed on Nasdaq with a market value of $ 38.74 Millions, having an equity of $ 75.24 Millions.

With a total of 70 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ -, which generated a loss in the amount of $ -65.30 Millions.

As for its main indicators, the Company has a P/E ratio of -0.59, a P/BV ratio of 0.51 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker NLTX.

Market cap

$ 38.74 Millions

Net worth

$ 75.24 Millions

US$ 75,235,000.00

Assets

$ 89.59 Millions

US$ 89,586,000.00

Total Shares Outstanding

11.10 Millions

11,101,000

Average Daily Trading Volume

$ 21.30 Thousand

US$ 21,304.74

Sector

Health Care

Industry

Biotechnology

NLTX

NLTX revenue and profits

Financial Results NLTX

DRAG THE FRAME TO SEE MORE DATA

NLTX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 813.80 41,98% (12M)

P/E

24.84

0.37%

ROE

-697.75%

P/BV

-173.31

CAH - Cardinal Health

$ 198.18 70,66% (12M)

P/E

29.67

1.02%

ROE

-58.40%

P/BV

-17.33

JNJ - Johnson & Johnson

$ 211.58 48,72% (12M)

P/E

20.28

2.43%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 100.30 2,85% (12M)

P/E

13.09

3.25%

ROE

0.00%

P/BV

0.00

PFE - Pfizer

$ 25.85 9,78% (12M)

P/E

14.95

6.65%

ROE

10.56%

P/BV

1.58

ABBV - AbbVie

$ 223.32 34,34% (12M)

P/E

168.68

2.88%

ROE

-91.88%

P/BV

-154.98

AZN - AstraZeneca

$ 89.83 37,80% (12M)

P/E

29.65

1.74%

ROE

20.45%

P/BV

6.06

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 813.80 41,98% (12 M)

P/L

24.84

0.37%

ROE

-697.75%

P/VP

-173.31

CAH - Cardinal Health

$ 198.18 70,66% (12 M)

P/L

29.67

1.02%

ROE

-58.40%

P/VP

-17.33

JNJ - Johnson & Johnson

$ 211.58 48,72% (12 M)

P/L

20.28

2.43%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 100.30 2,85% (12 M)

P/L

13.09

3.25%

ROE

0.00%

P/VP

0.00

PFE - Pfizer

$ 25.85 9,78% (12 M)

P/L

14.95

6.65%

ROE

10.56%

P/VP

1.58

ABBV - AbbVie

$ 223.32 34,34% (12 M)

P/L

168.68

2.88%

ROE

-91.88%

P/VP

-154.98

AZN - AstraZeneca

$ 89.83 37,80% (12 M)

P/L

29.65

1.74%

ROE

20.45%

P/VP

6.06

Frequently Asked Questions

What is the price of Neoleukin Therapeutics (NLTX) today?

The price of Neoleukin Therapeutics (NLTX) today is $ 0.00, with return of 0% compared to the last year. The price of Neoleukin Therapeutics (NLTX) started the year trading around $ 0.00 and today it is at $ 0.00. Follow the real-time price chart, the historical price of Neoleukin Therapeutics (NLTX) and international markets.

When does Neoleukin Therapeutics (NLTX) pay dividends?

Neoleukin Therapeutics (NLTX) did not distribute dividends in the last year.

Is Neoleukin Therapeutics (NLTX) worth it?

Currently, Neoleukin Therapeutics (NLTX) is priced at $ 0.00, with a P/E of -0.59%, representing a deviation of -4,691% from its historical average P/E. In the last year, the stock showed a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 0.00%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Neoleukin Therapeutics (NLTX) stock?

Investing in stocks of Neoleukin Therapeutics (NLTX) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Neoleukin Therapeutics (NLTX) yield today?

The yield of Neoleukin Therapeutics (NLTX) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Neoleukin Therapeutics (NLTX) today, the total investment would be $ 0.00, based on the current price of $ 0.00.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 0.00
In 5 years: $ 0.00
In 10 years: $ 0.00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

NLTX

Neoleukin Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of NLTX

review the fundamentals of Neoleukin Therapeutics shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT THE COMPANY Neoleukin Therapeutics

Neoleukin Therapeutics Inc.

United States

18 years

2014

70

PROFIT X PRICE NLTX

Financial Results NLTX

NLTX cash flow

asset growth - NLTX

NLTX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

Frequently Asked Questions